Parathyroid cancer: one of the rare cancer worldwide treated at SPHMMC
St Paul’s Hospital Millennium Medical College (SPHMMC) reports that a 40-year-old woman from Addis Ababa has been successfully treated for parathyroid cancer, one of the rarest cancers worldwide.
Parathyroid cancer affects only 3.5 to 7 people per 10 million annually, representing less than 1% of primary hyperparathyroidism cases and approximately 0.005% of all cancers globally. Its rarity makes diagnosis and treatment particularly challenging. Precise data on parathyroid cancer incidence in the Ethiopian population is not readily available and has not been formally recorded.
The patient underwent specialised surgery at SPHMMC, led by Dr Yishak Suga, Breast and Endocrine Surgery sub-specialist, with the support of two trainee surgeons. The procedure was successful, and the patient is currently in good health.
Dr Yishak highlighted that early diagnosis and access to specialised surgical care are critical in managing rare conditions such as parathyroid cancer. He also noted that this case reflects SPHMMC’s growing expertise and capacity in advanced endocrine surgery.
(In the photo, the lead surgeon, Dr. Yishak, is at the center, with Dr. Geremew, the fellow, on the right, and Dr. Sisay on the left.)
St Paul’s Hospital Millennium Medical College (SPHMMC) reports that a 40-year-old woman from Addis Ababa has been successfully treated for parathyroid cancer, one of the rarest cancers worldwide.
Parathyroid cancer affects only 3.5 to 7 people per 10 million annually, representing less than 1% of primary hyperparathyroidism cases and approximately 0.005% of all cancers globally. Its rarity makes diagnosis and treatment particularly challenging. Precise data on parathyroid cancer incidence in the Ethiopian population is not readily available and has not been formally recorded.
The patient underwent specialised surgery at SPHMMC, led by Dr Yishak Suga, Breast and Endocrine Surgery sub-specialist, with the support of two trainee surgeons. The procedure was successful, and the patient is currently in good health.
Dr Yishak highlighted that early diagnosis and access to specialised surgical care are critical in managing rare conditions such as parathyroid cancer. He also noted that this case reflects SPHMMC’s growing expertise and capacity in advanced endocrine surgery.
(In the photo, the lead surgeon, Dr. Yishak, is at the center, with Dr. Geremew, the fellow, on the right, and Dr. Sisay on the left.)
የፓራታይሮይድ ካንሰር
የፓራታይሮይድ ካንሰር እጅግ አልፎ አልፎ የሚገኝ የኤንዶክራይን ካንሰር አይነት ሲሆን፣ ከመጀመሪያ ደረጃ የፓራታይሮይድ በሽታ (primary hyperparathyroidism) መካከል ከ1% በታች ይሆናል። ይህ ካንሰር ከፓራታይሮይድ ግላንዶች ይመነጫል፤ እነዚህም በአካል ውስጥ የካልሲየም መጠንን በፓራታይሮይድ ሆርሞን (PTH) በመመራት የሚቆጣጠሩ አነስተኛ የኤንዶክራይን አካላት ናቸው።
የፓራታይሮይድ ካንሰር ብዙ ጊዜ በራሱ እብጠት ሳይሆን በሚያስከትለው ከባድ ፓራታይሮይድ ቅመም መብዛት ይገለጣል። ታካሚዎች እጅግ ከፍ ያለ የደም ካልሲየም እና PTH መጠን ሊኖራቸው ይችላል፣ ይህም የአጥንት ህመም፣ ስብራት፣ የኩላሊት ጠጠር፣ የጡንቻ ድካም፣ የአእምሮ ለውጦች እና የአንጀት ችግር እንዲታዩ ያደርጋል። ከተለመዱ የፓራታይሮይድ እብጠቶች በተለየ፣ የፓራታይሮይድ ካንሰር በአንገት ላይ የሚታይ እብጠት፣ የድምፅ ነርቭ (recurrent laryngeal nerve) መጎዳት ሊታይበት ይችላል።
ምርመራው አስቸጋሪ ሲሆን፣ ከቀዶ ጥገና በፊት የፓራታይሮይድ ካንሰርን መለየት አስቸጋሪ ነው። የምስል ምርመራዎች እብጠቱን ለመፈለግ ይረዳሉ፣ ነገር ግን ካንሰር መሆኑን መለየት ብቻቸውን አይችሉም። የመጨረሻ ምርመራ ብዙውን ጊዜ ከቀዶ ጥገና በኋላ በፓቶሎጂ ላይ ይመሰረታል።
ዋና የሕክምና መንገድ ቀዶ ጥገና ነው። እብጠቱን ከተጎዳው ፓራታይሮይድ ግላንድ እና ከአጎራባች ክፍሎች ጋር በአንድነት (en bloc resection) ማስወገድ ለፈውስ ከፍተኛ እድል ይሰጣል። ከሌሎች ብዙ ካንሰሮች በተለየ፣ የፓራታይሮይድ ካንሰር ለኬሞቴራፒ እና ራዲዮቴራፒ ዝቅተኛ ምላሽ ይሰጣል፤ ስለዚህ ቀድሞ መለየት እና ሙሉ ቀዶ ጥገና እጅግ አስፈላጊ ናቸው።
በቅርቡ ይህን እጅግ አልፎ አልፎ የሚገኝ በሽታ የፓራታይሮይድ ቀዶ ሕክምና በተደረገላት ሴት ታካሚ ላይ ሰሞኑን ተገኝቷል፡፡ ዶር ይሰሀሐቅ እና ባልደረቦቻቸው ባደረጉላቸው ቀዶ ሕክምና ታካሚዋ በአሁኑ ሰዓት በመልካም ሁኔታ ይገኛሉ፡፡
ምንም እንኳን እጅግ አልፎ አልፎ ቢሆንም፣ የፓራታይሮይድ ካንሰር በጊዜው ካልታወቀ ወይም በተገቢ መንገድ ካልታከመ ከፍተኛ ጉዳት ሊያመጣ ይችላል።
ስለዚህ፣ በሕክምና ባለሙያዎች እና ለዜጎች በህመሙ ዙሪያ ግንዛቤ ማሳደግ አስፈላጊ ነው፤ ምክንያቱም ቀድሞ ምርመራ እና ተገቢ የቀዶ ሕክምና ና በዚህ እጅግ አልፎ አልፎ የሚገኝ ነገር ግን ከባድ በሽታ ውጤትን በከፍተኛ ሁኔታ ሊያሻሽል ይችላል።
የፓራታይሮይድ ካንሰር እጅግ አልፎ አልፎ የሚገኝ የኤንዶክራይን ካንሰር አይነት ሲሆን፣ ከመጀመሪያ ደረጃ የፓራታይሮይድ በሽታ (primary hyperparathyroidism) መካከል ከ1% በታች ይሆናል። ይህ ካንሰር ከፓራታይሮይድ ግላንዶች ይመነጫል፤ እነዚህም በአካል ውስጥ የካልሲየም መጠንን በፓራታይሮይድ ሆርሞን (PTH) በመመራት የሚቆጣጠሩ አነስተኛ የኤንዶክራይን አካላት ናቸው።
የፓራታይሮይድ ካንሰር ብዙ ጊዜ በራሱ እብጠት ሳይሆን በሚያስከትለው ከባድ ፓራታይሮይድ ቅመም መብዛት ይገለጣል። ታካሚዎች እጅግ ከፍ ያለ የደም ካልሲየም እና PTH መጠን ሊኖራቸው ይችላል፣ ይህም የአጥንት ህመም፣ ስብራት፣ የኩላሊት ጠጠር፣ የጡንቻ ድካም፣ የአእምሮ ለውጦች እና የአንጀት ችግር እንዲታዩ ያደርጋል። ከተለመዱ የፓራታይሮይድ እብጠቶች በተለየ፣ የፓራታይሮይድ ካንሰር በአንገት ላይ የሚታይ እብጠት፣ የድምፅ ነርቭ (recurrent laryngeal nerve) መጎዳት ሊታይበት ይችላል።
ምርመራው አስቸጋሪ ሲሆን፣ ከቀዶ ጥገና በፊት የፓራታይሮይድ ካንሰርን መለየት አስቸጋሪ ነው። የምስል ምርመራዎች እብጠቱን ለመፈለግ ይረዳሉ፣ ነገር ግን ካንሰር መሆኑን መለየት ብቻቸውን አይችሉም። የመጨረሻ ምርመራ ብዙውን ጊዜ ከቀዶ ጥገና በኋላ በፓቶሎጂ ላይ ይመሰረታል።
ዋና የሕክምና መንገድ ቀዶ ጥገና ነው። እብጠቱን ከተጎዳው ፓራታይሮይድ ግላንድ እና ከአጎራባች ክፍሎች ጋር በአንድነት (en bloc resection) ማስወገድ ለፈውስ ከፍተኛ እድል ይሰጣል። ከሌሎች ብዙ ካንሰሮች በተለየ፣ የፓራታይሮይድ ካንሰር ለኬሞቴራፒ እና ራዲዮቴራፒ ዝቅተኛ ምላሽ ይሰጣል፤ ስለዚህ ቀድሞ መለየት እና ሙሉ ቀዶ ጥገና እጅግ አስፈላጊ ናቸው።
በቅርቡ ይህን እጅግ አልፎ አልፎ የሚገኝ በሽታ የፓራታይሮይድ ቀዶ ሕክምና በተደረገላት ሴት ታካሚ ላይ ሰሞኑን ተገኝቷል፡፡ ዶር ይሰሀሐቅ እና ባልደረቦቻቸው ባደረጉላቸው ቀዶ ሕክምና ታካሚዋ በአሁኑ ሰዓት በመልካም ሁኔታ ይገኛሉ፡፡
ምንም እንኳን እጅግ አልፎ አልፎ ቢሆንም፣ የፓራታይሮይድ ካንሰር በጊዜው ካልታወቀ ወይም በተገቢ መንገድ ካልታከመ ከፍተኛ ጉዳት ሊያመጣ ይችላል።
ስለዚህ፣ በሕክምና ባለሙያዎች እና ለዜጎች በህመሙ ዙሪያ ግንዛቤ ማሳደግ አስፈላጊ ነው፤ ምክንያቱም ቀድሞ ምርመራ እና ተገቢ የቀዶ ሕክምና ና በዚህ እጅግ አልፎ አልፎ የሚገኝ ነገር ግን ከባድ በሽታ ውጤትን በከፍተኛ ሁኔታ ሊያሻሽል ይችላል።
Parathyroid Carcinoma: A Rare but Important Diagnosis
Parathyroid carcinoma is an exceptionally rare endocrine malignancy, accounting for less than 1% of all cases of primary hyperparathyroidism and for less than 0.005% of all malignancies worldwide. It arises from the parathyroid glands, which are small endocrine organs responsible for regulating calcium homeostasis through the secretion of parathyroid hormone (PTH).
Clinically, parathyroid cancer most often presents not because of the tumor itself, but due to severe hyperparathyroidism. Patients may develop markedly elevated serum calcium and PTH levels, leading to symptoms such as bone pain, fractures, kidney stones, muscle weakness, neurocognitive changes, and gastrointestinal complaints. Unlike benign parathyroid adenomas, parathyroid carcinoma may present with a palpable neck mass, recurrent laryngeal nerve involvement, or persistent disease after surgery.
Diagnosis is challenging and is rarely made preoperatively. Imaging studies help localize the lesion but cannot reliably distinguish carcinoma from benign disease. Definitive diagnosis is usually established postoperatively based on histopathological features such as capsular and vascular invasion, local tissue infiltration, or metastasis.
Surgical excision remains the cornerstone of treatment. En bloc resection of the tumor with the involved parathyroid gland and adjacent tissues offers the best chance for cure. Unlike many other cancers, parathyroid carcinoma responds poorly to chemotherapy and radiotherapy, making early recognition and complete surgical management critical.
We recently encountered this rare entity in a woman who underwent parathyroidectomy, highlighting the importance of maintaining a high index of suspicion in patients with severe or atypical hyperparathyroidism. Although uncommon, parathyroid carcinoma carries significant morbidity if unrecognized or inadequately treated.
Raising awareness among clinicians and the wider community is essential, as early diagnosis and appropriate surgical management can significantly improve outcomes in this rare but serious disease.
Parathyroid carcinoma is an exceptionally rare endocrine malignancy, accounting for less than 1% of all cases of primary hyperparathyroidism and for less than 0.005% of all malignancies worldwide. It arises from the parathyroid glands, which are small endocrine organs responsible for regulating calcium homeostasis through the secretion of parathyroid hormone (PTH).
Clinically, parathyroid cancer most often presents not because of the tumor itself, but due to severe hyperparathyroidism. Patients may develop markedly elevated serum calcium and PTH levels, leading to symptoms such as bone pain, fractures, kidney stones, muscle weakness, neurocognitive changes, and gastrointestinal complaints. Unlike benign parathyroid adenomas, parathyroid carcinoma may present with a palpable neck mass, recurrent laryngeal nerve involvement, or persistent disease after surgery.
Diagnosis is challenging and is rarely made preoperatively. Imaging studies help localize the lesion but cannot reliably distinguish carcinoma from benign disease. Definitive diagnosis is usually established postoperatively based on histopathological features such as capsular and vascular invasion, local tissue infiltration, or metastasis.
Surgical excision remains the cornerstone of treatment. En bloc resection of the tumor with the involved parathyroid gland and adjacent tissues offers the best chance for cure. Unlike many other cancers, parathyroid carcinoma responds poorly to chemotherapy and radiotherapy, making early recognition and complete surgical management critical.
We recently encountered this rare entity in a woman who underwent parathyroidectomy, highlighting the importance of maintaining a high index of suspicion in patients with severe or atypical hyperparathyroidism. Although uncommon, parathyroid carcinoma carries significant morbidity if unrecognized or inadequately treated.
Raising awareness among clinicians and the wider community is essential, as early diagnosis and appropriate surgical management can significantly improve outcomes in this rare but serious disease.
Happy New Year 2026 from SPHMMC
As we step into 2026, all of us at St Paul’s Hospital Millennium Medical College (SPHMMC) want to send our warmest wishes to our partners, friends, and everyone celebrating today.
The New Year is a time to pause and reflect—on caring for each other, on kindness, and on the power of working together. We are truly grateful for your support and for being part of this journey with us.
Wishing you a 2026 filled with good health, joy, and renewed energy as we work side by side to make a positive impact on the lives of those we serve.
As we step into 2026, all of us at St Paul’s Hospital Millennium Medical College (SPHMMC) want to send our warmest wishes to our partners, friends, and everyone celebrating today.
The New Year is a time to pause and reflect—on caring for each other, on kindness, and on the power of working together. We are truly grateful for your support and for being part of this journey with us.
Wishing you a 2026 filled with good health, joy, and renewed energy as we work side by side to make a positive impact on the lives of those we serve.
Extension of Application Deadline
PhD Program in Public Health
The Registrar office is pleased to announce that the application deadline for the Doctor of Philosophy (PhD) in Public Health program has been extended.
New Deadline: January 17, 202
Original Deadline: January 03, 2025
This extension provides additional time for prospective applicants to prepare and submit their materials. We encourage candidates with strong academic backgrounds and a passion for advancing public health research to take advantage of this opportunity.
For application, use the link: https://portal.sphmmc.edu.et/Web/Announcement
PhD Program in Public Health
The Registrar office is pleased to announce that the application deadline for the Doctor of Philosophy (PhD) in Public Health program has been extended.
New Deadline: January 17, 202
Original Deadline: January 03, 2025
This extension provides additional time for prospective applicants to prepare and submit their materials. We encourage candidates with strong academic backgrounds and a passion for advancing public health research to take advantage of this opportunity.
For application, use the link: https://portal.sphmmc.edu.et/Web/Announcement
Successful Electrophysiology (EP) Medical Mission | SPHMMC – Adult Cardiology Division
St. Paul’s Hospital Millennium Medical College (SPHMMC) recently completed a three-day Electrophysiology (EP) medical mission through collaboration with international electrophysiology experts.
Key activities during the mission included:
🔹 7 EP studies and catheter ablations
🔹 7 pacemaker implantations, including left bundle branch pacing
🔹 Focused training, hands-on teaching, and capacity-building initiatives
SPHMMC acknowledges the valuable contribution of Dr. Franck Halimi🇫🇷, whose early efforts helped lay the foundation for Electrophysiology services in Ethiopia, together with the support of the Rhythm of Hope Foundation. Appreciation is also extended to Dr. Soufia Naccache 🇫🇷, Dr. Giusy Sirico 🇮🇹, and Dr. Martina Nesti 🇮🇹 for their clinical expertise, dedication to teaching, and collaborative engagement throughout the mission.
Such partnerships play an important role in strengthening specialized cardiac services and expanding access to advanced heart rhythm care in Ethiopia.
#SPHMMC #Electrophysiology #MedicalMission #InternationalCollaboration #CapacityBuilding #HeartRhythmCare
St. Paul’s Hospital Millennium Medical College (SPHMMC) recently completed a three-day Electrophysiology (EP) medical mission through collaboration with international electrophysiology experts.
Key activities during the mission included:
🔹 7 EP studies and catheter ablations
🔹 7 pacemaker implantations, including left bundle branch pacing
🔹 Focused training, hands-on teaching, and capacity-building initiatives
SPHMMC acknowledges the valuable contribution of Dr. Franck Halimi🇫🇷, whose early efforts helped lay the foundation for Electrophysiology services in Ethiopia, together with the support of the Rhythm of Hope Foundation. Appreciation is also extended to Dr. Soufia Naccache 🇫🇷, Dr. Giusy Sirico 🇮🇹, and Dr. Martina Nesti 🇮🇹 for their clinical expertise, dedication to teaching, and collaborative engagement throughout the mission.
Such partnerships play an important role in strengthening specialized cardiac services and expanding access to advanced heart rhythm care in Ethiopia.
#SPHMMC #Electrophysiology #MedicalMission #InternationalCollaboration #CapacityBuilding #HeartRhythmCare
Notification on the Launch of a New Institutional Repository:-
Dear members of the community,
We are pleased to inform you that St. Paul’s Hospital Millennium Medical College (SPHMMC) is transitioning from local repository to a new publicly accessible Institutional Repository. This centralized digital archive is designed to preserve and showcase the scholarly output of our college community in a robust and user-friendly platform.
The repository will host a diverse array of research works and institutional working documents produced by both current and past members of SPHMMC, including undergraduate and postgraduate students, and faculty members from various departments. This initiative has been developed in collaboration with a team of professionals from the Center of Excellence in Reproductive Health, ICT, and the College Library through the leadership of Research and Community Service Vice Corporate Director.
Visit the Repository at: https://repo.sphmmc.edu.et
Best regards,
Dear members of the community,
We are pleased to inform you that St. Paul’s Hospital Millennium Medical College (SPHMMC) is transitioning from local repository to a new publicly accessible Institutional Repository. This centralized digital archive is designed to preserve and showcase the scholarly output of our college community in a robust and user-friendly platform.
The repository will host a diverse array of research works and institutional working documents produced by both current and past members of SPHMMC, including undergraduate and postgraduate students, and faculty members from various departments. This initiative has been developed in collaboration with a team of professionals from the Center of Excellence in Reproductive Health, ICT, and the College Library through the leadership of Research and Community Service Vice Corporate Director.
Visit the Repository at: https://repo.sphmmc.edu.et
Best regards,
Today, on Christmas Day, we shared the joy of Christmas with our patients. Heartfelt thanks to Lisha Endale and her family from Switzerland for their generous support.